av/genocea-biosciences--big.svg

NASDAQ:GNCA

Genocea Biosciences, Inc.

  • Stock

USD

Last Close

0.00

22/12 19:54

Volume Today

30.27K

Avg: 80.57K

PE Ratio

0.00

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
-20.81M
-
-35.30M
69.64%
-42.48M
20.36%
-49.57M
16.69%
-56.71M
14.40%
-27.81M
50.96%
-38.95M
40.05%
-43.71M
12.23%
-33.20M
24.06%
depreciation and amortization
318K
-
469K
47.48%
1.05M
124.09%
1.81M
72.50%
1.52M
16.38%
1.09M
28.23%
1.10M
0.83%
1.14M
3.74%
1.56M
36.82%
deferred income tax
-50.56M
-
stock based compensation
672K
-
2.90M
332.29%
3.85M
32.46%
4.15M
7.77%
4.23M
2.10%
2.15M
49.15%
1.84M
14.68%
1.97M
7.46%
3.63M
84.14%
change in working capital
-501K
-
2.90M
678.04%
-1.14M
139.40%
1.30M
213.67%
1.85M
42.87%
-4.94M
366.76%
-1.32M
73.36%
3.04M
331.13%
2.17M
28.88%
accounts receivables
inventory
accounts payables
724K
-
516K
28.73%
-1.43M
377.33%
1.19M
183.16%
491K
58.74%
-2.10M
528.31%
-1.11M
47.41%
31K
102.80%
-57K
283.87%
other working capital
-1.23M
-
2.38M
294.29%
290K
87.82%
107K
63.10%
1.36M
1,172.90%
-2.84M
308.52%
-211K
92.57%
3.01M
1,527.96%
2.22M
26.25%
other non cash items
444K
-
1.42M
220.27%
369K
74.05%
481K
30.35%
1.51M
213.51%
-11.72M
877.32%
-401K
96.58%
-4.09M
920.70%
31.03M
858.15%
net cash provided by operating activities
-19.87M
-
-27.60M
38.90%
-38.36M
38.95%
-41.84M
9.07%
-47.60M
13.78%
-41.23M
13.37%
-37.73M
8.49%
-41.65M
10.38%
-45.37M
8.93%
investments in property plant and equipment
-389K
-
-1.52M
290.75%
-2.78M
83.16%
-2.54M
8.84%
-1.18M
53.59%
-241K
79.54%
-1.14M
370.95%
-2.58M
127.75%
-3.29M
27.20%
acquisitions net
purchases of investments
-27.05M
-
-89.65M
231.39%
-26.06M
70.93%
-153K
99.41%
sales maturities of investments
27.50M
-
79.31M
188.43%
36.09M
54.50%
other investing activites
150K
-
110K
26.67%
48K
56.36%
30K
37.50%
80K
166.67%
net cash used for investing activites
-389K
-
-28.57M
7,245.24%
-64.94M
127.27%
50.71M
178.09%
34.91M
31.16%
-131K
100.38%
-1.09M
729.77%
-2.56M
135.05%
-3.21M
25.56%
debt repayment
-4.25M
-
-10.40M
145.02%
-4K
99.96%
-3.15M
-
-535K
83.01%
-1.92M
258.69%
-134K
93.02%
-23K
82.84%
common stock issued
15.25M
-
61.94M
306.15%
95.18M
53.67%
815K
99.14%
246K
69.82%
55.46M
22,443.90%
54.67M
1.42%
83.84M
53.35%
11.35M
86.47%
common stock repurchased
dividends paid
other financing activites
9.95M
-
12.49M
25.54%
5.32M
57.45%
474K
91.08%
442K
6.75%
532K
20.36%
151K
71.62%
146K
3.31%
-5.37M
3,776.03%
net cash used provided by financing activities
20.95M
-
64.03M
205.56%
100.49M
56.96%
1.29M
98.72%
-2.46M
290.92%
55.45M
2,353.35%
52.90M
4.61%
83.85M
58.50%
5.96M
92.90%
effect of forex changes on cash
net change in cash
692K
-
7.85M
1,034.39%
-2.80M
135.66%
10.16M
463.17%
-15.15M
249.05%
14.09M
192.99%
14.08M
0.06%
39.64M
181.55%
cash at beginning of period
11.52M
-
12.21M
6.01%
20.06M
64.30%
17.26M
13.95%
27.42M
58.90%
12.59M
54.09%
26.68M
111.92%
40.76M
52.78%
80.40M
97.26%
cash at end of period
12.21M
-
20.06M
64.30%
17.26M
13.95%
27.42M
58.90%
12.27M
55.25%
26.68M
117.37%
40.76M
52.78%
80.40M
97.26%
80.40M
0%
operating cash flow
-19.87M
-
-27.60M
38.90%
-38.36M
38.95%
-41.84M
9.07%
-47.60M
13.78%
-41.23M
13.37%
-37.73M
8.49%
-41.65M
10.38%
-45.37M
8.93%
capital expenditure
-389K
-
-1.52M
290.75%
-2.78M
83.16%
-2.54M
8.84%
-1.18M
53.59%
-241K
79.54%
-1.14M
370.95%
-2.58M
127.75%
-3.29M
27.20%
free cash flow
-20.26M
-
-29.12M
43.74%
-41.14M
41.26%
-44.37M
7.86%
-48.78M
9.92%
-41.48M
14.97%
-38.87M
6.29%
-44.24M
13.81%
-48.66M
10.00%

All numbers in USD (except ratios and percentages)